Nuvectis Pharma Analyst Price Targets - Benzinga

Nuvectis Pharma Inc

NVCTNASDAQ

Trade with Public

Trade with Public

$18.43

-0.01-0.05%

Dern. MÀJ: Oct 27, 4:00 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Nuvectis Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nuvectis Pharma (NVCT).

Price Target Range — 7 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$27Upside to Avg. PT+46.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 24, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$39
Aug 24, 2026	Cantor Fitzgerald	Pete Stavropoulos	Initiate	Overweight	—
Jul 6, 2026	Roth Capital	Jonathan Aschoff	PT Raise	Buy	$20→$33
Jun 22, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$13→$39
Jun 12, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$10→$13
Aug 4, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$15→$10
Apr 30, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$11→$15
Apr 2, 2025	Maxim Group	Naz Rahman	Initiate	Buy	$17
Mar 17, 2025	Laidlaw & Co.	Yale Jen	Initiate	Buy	$19
Feb 25, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$21→$11
Aug 6, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
May 8, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $39 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $39 price target.

Benzinga Newsdesk

This Cal-Maine Foods Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Analysts downgraded UiPath, Cal-Maine with several price-target cuts.

Avi Kapoor

This Toast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday

Wall Street analysts changed outlook on top companies. Check out complete rating changes, including upgrades/downgrades, on our page.

Avi Kapoor

This PG&E Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital

Avi Kapoor

This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst

Avi Kapoor

This Deere Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst

Avi Kapoor